The long-term effects of dietary flaxseed and tocopherols on hepatic and blood plasma lipids, fatty acids, tocopherols, hepatic TBA reactive substances, and histopathology of Brown Leghorn hens were investigated. Thirty-two-week-old ISA Brown Leghorn hens (n = 120) were kept in cages and were fed 1 of the 3 corn-soybean meal-based diets, a control diet (no flax) or a 10% flax diet with or without 100 IU of tocopherols, until the hens were 64 wk of age. Feeding diets with 10% flaxseed reduced hepatic and plasma fat content, hepatic triglycerides, total number of fat vacuoles, and number of cells with 75% or higher lipid infiltration in hepatocytes (P < 0.05). Addition of tocopherols to the 10% flax diet increased hepatic and plasma tocopherol content. A significant reduction in hepatic TBA reactive substances was observed in the hens supplemented with the basal diet with 10% flax and 100 IU of tocopherols (P < 0.05). Feeding diets containing flaxseed resulted in an increase in the content of alpha-linolenic (18: n-3) and docosahexaenoic acids (22:6n-3), with a concomitant reduction in monounsaturated and saturated fatty acids in the hen liver and plasma. Overall, long-term feeding of hens with flax led to a reduction in liver and plasma lipids and reduced hepatocellular infiltration. Inclusion of tocopherols may be needed to reduce lipid oxidation products in the liver of flax-fed hens. However, tocopherol supplementation had no effect on hepatocellular lipid infiltration or liver total lipid or triglyceride content.
No takes yet. Share an insight, caveat, or question.
Cherian et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: